Searched for
GLENMARK REVENUE DECLINE
Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 crGlenmark Pharmaceuticals experienced a 56.78 percent drop in consolidated profit after tax during the September quarter. Total revenue from...- Pills are paying off! Pharma stocks lead 2026 rally with up to 112% returnIn 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic dem...
- Glenmark Pharma will turn cash positive with AbbVie's licensing deal: S&PS&P Global Ratings projects Glenmark Pharmaceuticals will achieve a net cash positive position following its licensing agreement with AbbVi...
- Glenmark shares in focus after recall of 15 lakh bottles of ADHD drug in USGlenmark share price: The recall affects around 14.76 lakh bottles of Atomoxetine Capsules in various strengths, produced by Glenmark Pharm...
- Glenmark Pharma shares in focus as company swings back to profit in Q3Glenmark Pharmaceuticals reported a net profit of Rs 348 crore for Q3FY25, a significant turnaround from a Rs 351 crore loss in the previou...
- Glenmark Pharma Q2 Results: Co posts Rs 355 crore net profit on robust sales growthGlenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net los...
- Stocks in news: Ola Electric, Hindustan Zinc, SpiceJet, SBI, Glenmark PharmaStocks in news: The domestic markets closed flat on Wednesday. Hindustan Zinc set a floor price of Rs 486 for its offer for sale. SpiceJet’...
- Glenmark Pharma Q4 Results: Net loss widens to Rs 121 crore YoYGlenmark Pharma Q4 Results: The rise in loss was on account of declining sales in the US and exceptional items. It had reported a net loss ...
- Glenmark Life Q4 Results: Net profit dips 33% to Rs 98 croreGlenmark Life Sciences on Thursday said its net profit declined 33 per cent to Rs 98 crore for the March quarter ended March 31, 2024. The ...
- Glenmark Q3 Results: Co reports net loss of Rs 351 cr on lower domestic salesTotal revenue from operations declined to Rs 2,507 crore as compared with Rs 3,100 crore in the year-ago period, Glenmark Pharma said in a ...
- Glenmark reports Rs 403 crore loss in Q4FY23For the fourth quarter of FY23, Glenmark’s consolidated revenue was at Rs. 3374 crore as against Rs.3019 crore in the same quarter of previ...
- Glenmark Q2 Results: Net profit rises 1.4% YoY to Rs 278 croreRevenues rose 7.2% YoY to Rs 3,375 crore during Q2FY23 as against Rs 3,147 crore in Q2FY22
- Add Glenmark Pharmaceuticals, target price Rs 607: ICICI SecuritiesGlenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 14885.78 Crore) operating in ...
- Glenmark in talks to sell up to 30% in API biz to PremjiInvestThe pharma group plans to sell minority stake for $150m in their new subsidiary of active pharmaceutical ingredient products. Discussions a...
- Hold Glenmark Pharmaceuticals, Rs 530: EdelweissHold Glenmark Pharmaceuticals Ltd. at a price target of Rs 530.0 .
- Glenmark Pharma shares dive 10% after Q3 earningsGlenmark on Thursday said its net profit dropped 78 per cent to Rs 104.7 crore.
- Glenmark Pharma hits 52-week high, analysts recommend ‘buy’The company company had posted a net profit of Rs 208.58 crore during the same period of the previous fiscal, Glenmark Pharmaceuticals said...
- Glenmark recalls child epilepsy drug in USGlenmark is recalling specific lots of its Oxcarbazepine tablets, used for the treatment of child epilepsy, in the US over a labelling erro...
- Glenmark to reorganise biz into two unitsThe company’s generic business will come under a wholly owned subsidiary, Glenmark Generics, while innovative research initiatives and bran...
- Glenmark on a highGlenmark Pharma’s sales in the quarter ended June’06 increased 27% to Rs 192 crore, led by its international formulation business.
Load More
